#AANAM – Analysis Estimates 2,700 ATTRv Amyloidosis Patients in US

#AANAM – Analysis Estimates 2,700 ATTRv Amyloidosis Patients in US

293916

#AANAM – Analysis Estimates 2,700 ATTRv Amyloidosis Patients in US

Editor’s note: The FAP News Today team provided in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. There are roughly 2,700 people in the U.S. with hereditary transthyretin (ATTRv) amyloidosis, a group of rare disorders that also includes familial amyloid polyneuropathy (FAP), a new analysis estimates. Findings from this analysis were featured in a poster, “Use of Commercial Claims Data to Estimate Hereditary Transthyretin-Mediated…

You must be logged in to read/download the full post.